Treatment strategy of EGFR-mutated non-small cell lung cancer

被引：1
|
作者：
Tanaka, Fumihiro [1 ]
Yoneda, Kazue [1 ]
Takenaka, Masaru [1 ]
Kuroda, Koji [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Dept Surg Chest Surg 2, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2022年 / 14卷 / 03期
关键词：
OSIMERTINIB; PATIENT; MUTATIONS; SURGERY;
D O I：
10.21037/jtd-22-177
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：602 / 606
页数：5
相关论文
共 50 条
  • [21] Deciphering the Characterization of Tumor Microenvironment in EGFR-Mutated Non-Small Cell Lung Cancer
    Qiao, M.
    Jiang, T.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S182 - S183
  • [22] Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
    Steendam, Christi M. J.
    Veerman, G. D. Marijn
    Pruis, Melinda A.
    Atmodimedjo, Peggy
    Paats, Marthe S.
    van der Leest, Cor
    von der Thusen, Jan H.
    Yick, David C. Y.
    Oomen-de Hoop, Esther
    Koolen, Stijn L. W.
    Dinjens, Winand N. M.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    Aerts, Joachim G. J. V.
    Dubbink, Hendrikus Jan
    Dingemans, Anne-Marie C.
    CANCERS, 2020, 12 (11) : 1 - 17
  • [23] Plasma metabolite biomarkers for EGFR-mutated non-small cell lung cancer (NSCLC)
    Thamlikitkul, Lucksamon
    Manocheewa, Siriphan
    Limjiasahapong, Suphitcha
    Wanichthanarak, Kwanjeera
    Panya, Atikorn
    Poungvarin, Naravat
    Pomyen, Yotsawat
    Khoomrung, Sakda
    CANCER RESEARCH, 2024, 84 (06)
  • [24] RNA Sequencing to Characterize Pathways in EGFR-mutated Non-Small Cell Lung Cancer
    Yun, N.
    Naqib, A.
    Borgia, J. A.
    Fidler, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S458 - S459
  • [25] RNA sequencing to characterize pathways in EGFR-mutated non-small cell lung cancer
    Yun, Nicole
    Naqib, Ankur D.
    Borgia, Jeffrey Allen
    Batus, Marta
    Fidler, Mary Jo J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Progression of leptomeningeal metastases in advanced EGFR-mutated non-small cell lung cancer
    Zhao, Q.
    Deng, L.
    Zhang, Y.
    Zhou, X.
    Li, Y.
    Yu, M.
    Zhou, L.
    Zou, B.
    Liu, Y.
    Lu, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung Cancer
    Lara-Mejia, Luis
    Sanchez-Reyes, Roberto
    Aviles-Salas, Alejandro
    Arrieta-Rodriguez, Oscar
    ONCOLOGY-NEW YORK, 2020, 34 (01): : 21 - 27
  • [28] Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Sequist, L. V.
    Soria, J-C
    Goldman, J. W.
    Wakelee, H. A.
    Gadgeel, S. M.
    Varga, A.
    Papadimitrakopoulou, V.
    Solomon, B. J.
    Oxnard, G. R.
    Dziadziuszko, R.
    Aisner, D. L.
    Doebele, R. C.
    Galasso, C.
    Garon, E. B.
    Heist, R. S.
    Logan, J.
    Neal, J. W.
    Mendenhall, M. A.
    Nichols, S.
    Piotrowska, Z.
    Wozniak, A. J.
    Raponi, M.
    Karlovich, C. A.
    Jaw-Tsai, S.
    Isaacson, J.
    Despain, D.
    Matheny, S. L.
    Rolfe, L.
    Allen, A. R.
    Camidge, D. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18): : 1700 - 1709
  • [29] Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    He, Yong
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06): : 578 - 578
  • [30] Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
    Eltayeb, Kamal
    La Monica, Silvia
    Tiseo, Marcello
    Alfieri, Roberta
    Fumarola, Claudia
    CELLS, 2022, 11 (03)
12345